Your search returned 199 results.

Sort
Results
EMCDDA-Europol joint report on a new psychoactive substance : methoxetamine (2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone) [PDF] by
  • European Monitoring Centre for Drugs and Drug Addiction [EMCDDA]
  • Europol
Language: Engels
Publication details: Lisbon EMCDDA 2014
Availability: Items available for reference: VAD: Not for loan (1).
EMCDDA–Europol joint report on a new psychoactive substance: MDPV (3,4-methylenedioxypyrovalerone) [PDF] by
  • European Monitoring Centre for Drugs and Drug Addiction [EMCDDA]
  • Europol
Language: Engels
Publication details: Lisbon EMCDDA 2014
Availability: Items available for reference: VAD: Not for loan (1).
EMCDDA–Europol Joint Report on a new psychoactive substance: AH-7921 (3,4-dichloro--[[1-(dimethylamino)cyclohexyl]methyl]benzamide) [PDF] by
  • European Monitoring Centre for Drugs and Drug Addiction [EMCDDA]
  • Europol
Language: Engels
Publication details: Lisbon EMCDDA 2014
Availability: Items available for reference: VAD: Not for loan (1).
EMCDDA–Europol Joint Report on a new psychoactive substance: 25I-NBOMe (4-iodo-2,5-dimethoxy--(2-methoxybenzyl)phenethylamine) [PDF] by
  • European Monitoring Centre for Drugs and Drug Addiction [EMCDDA]
  • Europol
Language: Engels
Publication details: Lisbon EMCDDA 2014
Availability: Items available for reference: VAD: Not for loan (1).
Pregnancy, childcare and the family : key issues for Europe's response to drugs by
  • European Monitoring Centre for Drugs and Drug Addiction [EMCDDA]
Language: Engels
Publication details: Lisbon EMCDDA 2012
Availability: Items available for loan: VAD (1)Call number: BOX25.
4,4′-DMAR : EMCDDA–Europol Joint Report on a new psychoactive substance: 4,4′-DMAR (4-methyl-5- (4-methylphenyl)-4,5-dihydrooxazol-2-amine) [PDF] by
  • European Monitoring Centre for Drugs and Drug Addiction [EMCDDA]
  • Europol
Language: Engels
Publication details: Lisbon EMCDDA 2014
Availability: Items available for reference: VAD: Not for loan (1).
European drug report : trends and developments : 2014 [PDF] by
  • European Monitoring Centre for Drugs and Drug Addiction [EMCDDA]
Language: Engels
Publication details: Lissabon EMCDDA 2014
Availability: Items available for reference: VAD: Not for loan (1).
MT-45 : EMCDDA–Europol joint report on a new psychoactive substance: 1-cyclohexyl-4-(1,2-diphenylethyl)piperazine (‘MT-45’) [PDF] by
  • European Monitoring Centre for Drugs and Drug Addiction [EMCDDA]
  • Europol
Language: Engels
Publication details: Lisbon EMCDDA 2014
Availability: Items available for reference: VAD: Not for loan (1).
Pregnancy and opioid use : strategies for treatment [PDF] by
  • European Monitoring Centre for Drugs and Drug Addiction [EMCDDA]
Series: EMCDDA papersLanguage: Engels
Publication details: Lisbon EMCDDA 2014
Availability: Items available for reference: VAD: Not for loan (1).
Pregnancy and opioid use : strategies for treatment [PDF] by
  • European Monitoring Centre for Drugs and Drug Addiction [EMCDDA]
Series: EMCDDA papersLanguage: Engels
Publication details: Lisbon EMCDDA 2014
Availability: Items available for reference: VAD: Not for loan (1).
Preventing fatal overdoses: a systematic review of the effectiveness of take-home naloxone [PDF] by
  • European Monitoring Centre for Drugs and Drug Addiction [EMCDDA]
Series: EMCDDA papersLanguage: Engels
Publication details: Lisbon EMCDDA 2015
Availability: Items available for reference: VAD: Not for loan (1).
Guidelines for the evaluation of treatment in the field of problem drug use : a manual for researchers and professionals [PDF] by
  • European Monitoring Centre for Drugs and Drug Addiction [EMCDDA]
Series: EMCDDA manuals ; 3Language: Engels
Publication details: Lisbon EMCDDA 2007
Availability: Items available for reference: VAD: Not for loan (1).
European drug report : trends and developments : 2015 [PDF] by
  • European Monitoring Centre for Drugs and Drug Addiction [EMCDDA]
Language: Engels
Publication details: Lissabon EMCDDA 2015
Availability: Items available for reference: VAD: Not for loan (1).
Annual report : the state of the drugs problem in Europe : 2008 [PDF] by
  • European Monitoring Centre for Drugs and Drug Addiction [EMCDDA]
Language: Engels
Publication details: Lisboa EMCDDA 2008
Availability: Items available for reference: VAD: Not for loan (1).
EMCDDA–Europol Joint Report on a new psychoactive substance: 1-phenyl-2-(1-pyrrolidinyl)-1-pentanone (α-PVP) [PDF] by
  • European Monitoring Centre for Drugs and Drug Addiction [EMCDDA]
  • Europol
Series: Joint reportsLanguage: Engels
Publication details: Lisbon EMCDDA 2015
Availability: Items available for reference: VAD: Not for loan (1).
EU drug markets report : in-depth analysis [PDF] by
  • European Monitoring Centre for Drugs and Drug Addiction [EMCDDA]
  • Europol
Language: Engels
Publication details: Lisbon EMCDDA 2016
Availability: Items available for reference: VAD: Not for loan (1).
Prosecution of drug users in Europe : varying pathways to similar objectives [PDF] by
  • European Monitoring Centre for Drugs and Drug Addiction [EMCDDA]
Series: EMCDDA insight series ; 5Language: Engels
Publication details: Lisboa EMCDDA 2002
Availability: Items available for reference: VAD: Not for loan (1).
Guidelines for collecting data on retail drug prices in Europe : issues and challenges [PDF] by
  • European Monitoring Centre for Drugs and Drug Addiction [EMCDDA]
Series: EMCDDA manuals ; 5Language: Engels
Publication details: Lisbon EMCDDA 2010
Availability: Items available for reference: VAD: Not for loan (1).
Towards a better understanding of drug-related public expenditure in Europe [PDF] by
  • European Monitoring Centre for Drugs and Drug Addiction [EMCDDA]
Language: Engels
Publication details: Lisbon EMCDDA 2008
Availability: Items available for reference: VAD: Not for loan (1).
Risk assessment of new psychoactive substances : operating guidelines [PDF] by
  • European Monitoring Centre for Drugs and Drug Addiction [EMCDDA]
Language: Engels
Publication details: Lisbon EMCDDA 2009
Availability: Items available for reference: VAD: Not for loan (1).
Pages